🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Traditional management of community-acquired pneumonia (CAP) relies on the ...
Status
Completed
Location
4th Department of Internal Medicine, Attikon University Hospital
Start Date
2021-01-25
Trial ID
NCT04724044
Treatments Being Tested
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00876850
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
The purpose of the study is to assess the effect of folic acid administrati...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00709332
Treatments Being Tested
An open label, balanced, randomized, two-treatment, two-period, two-sequenc...
Status
Completed
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT02322619
Treatments Being Tested
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the...
Status
Terminated
Location
Paratek Recruiting Site
Start Date
2009-04-04
Trial ID
NCT00865280
Treatments Being Tested
This is a Phase 1, double-blind, randomized, repeat-dose, single -dite, 4-a...
Status
Completed
Location
Research Site 1
Start Date
2008-05
Trial ID
NCT00675701
Treatments Being Tested
The study will investigate whether administration of clazosentan can affect...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2018-09-18
Trial ID
NCT03657446
Treatments Being Tested
The main objective of this trial is to evaluate the effects of a single the...
Status
Completed
Location
Quotient Sciences
Start Date
2024-03-06
Trial ID
NCT06107036
Treatments Being Tested
The effect of multiple oral administration of two doses of CG5503 PR (prolo...
Status
Completed
Location
DE001 - Contract research organisation
Start Date
2003-03
Trial ID
NCT03951402